⌘K

Home/Filings/4/0001062993-21-002792

4//SEC Filing

Breton Jose 4

Accession 0001062993-21-002792

CIK 0000819050other

View on SEC.gov Company Profile

Filed

Mar 16, 8:00 PM ET

Accepted

Mar 17, 4:54 PM ET

Size

8.3 KB

Accession

0001062993-21-002792

Insider Transaction Report

Form 4

Period: 2021-03-16

Brickell Biotech, Inc.BBI

Chief Accounting Officer

Transactions

Exercise/Conversion
Common Stock
2021-03-16+15,000→ 17,169 total
Exercise/Conversion
Restricted Stock Units
2021-03-16−15,000→ 0 total
→ Common Stock (15,000 underlying)
Tax Payment
Common Stock
2021-03-16$1.14/sh−5,250$5,985→ 11,919 total

Footnotes (3)

[F1]Restricted stock units ("RSUs") converted into common stock on a one-for-one basis.
[F2]Represents shares withheld to satisfy tax withholding obligations upon the vesting of RSUs.
[F3]These RSUs vested in full on March 16, 2021.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Brickell Biotech, Inc.

CIK 0000819050

Entity typeother

Related Parties

1

filerCIK 0001784373

Filing Metadata

Form type: 4
Filed: Mar 16, 8:00 PM ET
Accepted: Mar 17, 4:54 PM ET
Size: 8.3 KB

View on SEC.gov